PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review

被引：23

作者：

Song, Jiachun ^{[1
]}

Lan, Jinxin ^{[1
]}

Tang, Jiaping ^{[1
]}

Luo, Na ^{[1
]}

机构：

[1] Nankai Univ, Sch Med, Dept Anat & Histol, Tianjin 300071, Peoples R China

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 17期

基金：

中国国家自然科学基金;

关键词：

PTPN2; inflammation; tumor immunotherapy; PROTEIN-TYROSINE-PHOSPHATASE; BLOOD-BRAIN-BARRIER; NEGATIVE REGULATOR; ACTIVATION; IDENTIFICATION; TCPTP; PROLIFERATION; FAMILY; DIFFERENTIATION; LOCALIZATION;

D O I：

10.3390/ijms231710025

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

PTPN2 (protein tyrosine phosphatase non-receptor 2), also called TCPTP (T cell protein tyrosine phosphatase), is a member of the PTP family signaling proteins. Phosphotyrosine-based signaling of this non-transmembrane protein is essential for regulating cell growth, development, differentiation, survival, and migration. In particular, PTPN2 received researchers' attention when Manguso et al. identified PTPN2 as a cancer immunotherapy target using in vivo CRISPR library screening. In this review, we attempt to summarize the important functions of PTPN2 in terms of its structural and functional properties, inflammatory reactions, immunomodulatory properties, and tumor immunity. PTPN2 exerts synergistic anti-inflammatory effects in various inflammatory cells and regulates the developmental differentiation of immune cells. The diversity of PTPN2 effects in different types of tumors makes it a potential target for tumor immunotherapy.

引用

页数：14

共 50 条

[31] The role of the gut microbiota in tumor, immunity, and immunotherapy [J].

Xie, Yuyan ;

Liu, Fang .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[32] PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation [J].

Spalinger, Marianne R. ;

Scharl, Michael .

MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (04)

[33] PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer [J].

Elin Karlsson ;

Cynthia Veenstra ;

Jon Gårsjö ;

Bo Nordenskjöld ;

Tommy Fornander ;

Olle Stål .

Journal of Cancer Research and Clinical Oncology, 2019, 145 :599-607

[34] PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer [J].

Karlsson, Elin ;

Veenstra, Cynthia ;

Garsjo, Jon ;

Nordenskjold, Bo ;

Fornander, Tommy ;

Stal, Olle .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (03) :599-607

[35] Association Between the PTPN2 Gene and Crohn's Disease: Dissection of Potential Causal Variants [J].

Marcil, Valerie ;

Mack, David R. ;

Kumar, Vijay ;

Faure, Christophe ;

Carlson, Christopher S. ;

Beaulieu, Patrick ;

Israel, David ;

Krupoves, Alfreda ;

Costea, Irina ;

Lambrette, Philippe ;

Grimard, Guy ;

Dong, Jinsong ;

Seidman, Ernest G. ;

Amre, Devendra K. ;

Levy, Emile .

INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) :1149-1155

[36] PTPN2 regulates T cell lineage commitment and αβ versus γδ specification [J].

Wiede, Florian ;

Dudakov, Jarrod A. ;

Lu, Kun-Hui ;

Dodd, Garron T. ;

Butt, Tariq ;

Godfrey, Dale I. ;

Strasser, Andreas ;

Boyd, Richard L. ;

Tiganis, Tony .

JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (09) :2733-2758

[37] Association of genetic variations in PTPN2 and CD122 with ocular Behcet's disease [J].

Zhang, Qi ;

Li, Hua ;

Hou, Shengping ;

Yu, Hongsong ;

Su, Guannan ;

Deng, Bolin ;

Qi, Jian ;

Zhou, Chunjiang ;

Kijlstra, Aize ;

Yang, Peizeng .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (07) :996-1002

[38] Modulation of STAT3 phosphorylation by PTPN2 inhibits naive pluripotency of embryonic stem cells [J].

Zhang, Yan ;

Ding, Huiwen ;

Wang, Xiaohu ;

Ye, Shou-Dong .

FEBS LETTERS, 2018, 592 (13) :2227-2237

[39] Stem-Cell-Derived β-Like Cells with a Functional PTPN2 Knockout Display Increased Immunogenicity [J].

Triolo, Taylor M. M. ;

Matuschek, J. Quinn ;

Castro-Gutierrez, Roberto ;

Shilleh, Ali H. H. ;

Williams, Shane P. M. ;

Hansen, Maria S. S. ;

McDaniel, Kristen ;

Barra, Jessie M. M. ;

Michels, Aaron ;

Russ, Holger A. A. .

CELLS, 2022, 11 (23)

[40] PTPN2 mutations cause epithelium-intrinsic barrier loss that synergizes with mucosal immune hyperactivation [J].

Sweat, Yan Y. ;

Turner, Jerrold R. .

JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (17)

← 1 2 3 4 5 →